GSK (SA)

Active
VAT

BE 0403.066.474

Full name
GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline
Address
Avenue Fleming 20
1300 Wavre
Established
01-01-1968
Principal activity
Wholesale trade of pharmaceutical goods

Crisis resilience of GSK

Which companies are best armed against current economic trends and the energy crisis?

Read more

Financial data of GSK

2022 Financial statements 2021 Financial statements 2020 Financial statements 2019 Financial statements
Turnover €156,101,547
8%
€144,795,962
-2%
€147,689,966
-11%
€165,043,240
Profit/Loss €2,425,065
-19%
€3,006,171
-1%
€3,047,513
-17%
€3,670,683
Equity €21,227,268
-3%
€21,808,374
16%
€18,802,203
19%
€15,754,690
Gross margin €49,014,751
14%
€42,835,939
5%
€40,809,465
-14%
€47,718,629
Employees 189,2 FTE
-2%
193,3 FTE
8%
178,8 FTE
1%
176,2 FTE

Frequently asked questions

What is the VAT number of GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline?
The VAT number of GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline is BE0403066474.
When was GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline founded?
GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline was founded on 01-01-1968.
What is the address of GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline?
The current registered office of GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline is located at Avenue Fleming 20, 1300 Wavre.
When was the last time GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline filed their annual financial statements?
The most recent financial statements of GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline were filed on 15-07-2023. You can view them here.
How many employees does GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline have?
There are 189,2 FTEs working at GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline according to the staff figures in the most recent financial statements.
What is the annual turnover of GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline?
At the time of its most recent financial statements, GlaxoSmithKline Pharmaceuticals en abrégé GlaxoSmithKline recorded a total turnover of €156,101,552.00.
Address

  You have disabled Javascript on your computer. To use this website, please enable Javascript first.


More details